Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Afghanistan
Afghanistan: Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati was 63.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunizati in Afghanistan, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
Afghanistan recorded 63.0% for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in 2025.
The figure is up 1.6% on the previous year and down 1.6% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Afghanistan peaked at 64.0% in 2015 and was at its lowest, 0.0%, in 2008.
That places Afghanistan 142nd out of 194 countries with data for 2025, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 36.3% | 0.0% | 64.0% | 10 |
| 2020s | 59.2% | 53.0% | 63.0% | 6 |
Countries ranked near Afghanistan
- 141 Benin 64.0% compare
- 142 Democratic Republic of Congo 63.0% compare
- 144 Marshall Islands 62.0% compare
- 144 Laos 62.0% compare
- 144 Nigeria 62.0% compare
More health data for Afghanistan
- Un projection of annual infant deaths 14,735 (2100)
- Heat deaths vs projected death rates 812.4 (2090)
- Deaths in armed conflicts by country 454 (2026)
- Deaths in armed conflicts by region 454 (2026)
- Age population, age 08, male, interpolated 621,653 (2025)
- Age population, age 11, female, interpolated 556,537 (2025)
- Age population, age 10, male, interpolated 595,588 (2025)
- Age population, age 10, female, interpolated 569,129 (2025)
- Age population, age 09, male, interpolated 608,382 (2025)
- Age population, age 09, female, interpolated 581,669 (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Afghanistan?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati in Afghanistan was 63.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Afghanistan?
- The highest recorded value was 64.0% in 2015.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati recorded in Afghanistan?
- The lowest recorded value was 0.0% in 2008.
- How does Afghanistan rank for pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati?
- Afghanistan ranks 142nd out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) immunizati rising or falling in Afghanistan?
- Over the last ten years it is down 1.6%. The long-run trend across the full record is volatile.
- Where does this Afghanistan data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).